The stock price of Illumina, best known for its genetic variation and biological function systems, has seen a 3x growth since the end of 2017. But how did the company pull off such impressive gains, as its revenues grew 45% over the same period? Well, there is a valid reason, of course…
Source: Forbes Markets
